Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

(2014) Kyle C. Cuneo et al.   Translational Oncology

Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology

(2013) Francesco De Cobelli et al.   EUROPEAN RADIOLOGY

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

(2013) Hideki Ueno et al.   JOURNAL OF CLINICAL ONCOLOGY

Head and Neck Squamous Cell Carcinoma: Diagnostic Performance of Diffusion-weighted MR Imaging for the Prediction of Treatment Response

(2012) Ann D. King et al.   RADIOLOGY

Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer

(2012) Romain Altwegg   WORLD JOURNAL OF GASTROENTEROLOGY

Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer

(2011) H. Ueno et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer

(2010) Michael Haas et al.   TUMOR BIOLOGY

Early Detection of Therapeutic Response to Hepatic Arterial Infusion Chemotherapy of Liver Metastases from Colorectal Cancer Using Diffusion-Weighted MR Imaging

(2009) Nagaaki Marugami et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck

(2009) S. Kim et al.   CLINICAL CANCER RESEARCH

Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

(2009) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

(2009) David Cunningham et al.   JOURNAL OF CLINICAL ONCOLOGY

Locally Advanced Rectal Carcinoma Treated with Preoperative Chemotherapy and Radiation Therapy: Preliminary Analysis of Diffusion-weighted MR Imaging for Early Detection of Tumor Histopathologic Downstaging

(2009) Ying-Shi Sun et al.   RADIOLOGY

Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy

(2008) T NIWA et al.   BRITISH JOURNAL OF RADIOLOGY

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

(2008) Henry Q. Xiong et al.   CANCER

Apparent diffusion coefficient in pancreatic cancer: Characterization and histopathological correlations

(2008) Noriaki Muraoka et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: Usefulness in characterizing solid pancreatic masses

(2008) Seung Soo Lee et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

(2008) Viviane Hess et al.   LANCET ONCOLOGY

Apparent Diffusion Coefficient: Potential Imaging Biomarker for Prediction and Early Detection of Response to Chemotherapy in Hepatic Metastases

(2008) Yong Cui et al.   RADIOLOGY

Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine

(2006) Akira Sawaki et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY